Literature DB >> 34611834

Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.

Brian I Carr1, Vito Guerra2, Rossella Donghia2, Seai Yilmaz3.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) aggressiveness factors include serum levels of alpha-fetoprotein (AFP), maximum tumor diameter (MTD), tumor multifocality, and presence of portal vein thrombosis (PVT). AIMS: The interdependence of these factors has not been closely studied.
METHODS: A large HCC database was examined for the presence of patients with PVT and multifocality and was analyzed retrospectively for the relationship of these 2 parameters to each other and to MTD and survival.
RESULTS: Multifocality was found to increase with increase in MTD in the whole cohort and especially in patients with PVT. PVT also increased with increasing MTD. Neither increases in multifocality nor in PVT depended on elevated serum AFP levels, although they each increased with higher AFP levels. PVT increased in monofocal tumors as MTD increased but increased further in multifocal tumors.
CONCLUSIONS: Multifocality and PVT appear to be separate processes, each increasing with increase in MTD and AFP levels. The data support the hypothesis that in hepatocarcinogenesis, various factors cause increase in MTD, that in turn causes increased multifocality and PVT, which are non-co-dependent. However, both multifocality and PVT mechanisms involve both HCC cell growth and invasiveness, multifocality in liver parenchyma, and PVT in the portal vein.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Focality; HCC; PVT; Relative risk ratio; Survival

Mesh:

Substances:

Year:  2021        PMID: 34611834      PMCID: PMC8799496          DOI: 10.1007/s12029-021-00720-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  42 in total

1.  Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.

Authors:  Xiao Xu; Xuyong Wei; Qi Ling; Jun Cheng; Bin Zhou; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  J Gastroenterol Hepatol       Date:  2011-12       Impact factor: 4.029

Review 2.  Computed tomography in the evaluation of the portal venous system.

Authors:  C R Taylor
Journal:  J Clin Gastroenterol       Date:  1992-03       Impact factor: 3.062

3.  Benign and malignant portal vein thrombosis: differentiation by CT characteristics.

Authors:  M E Tublin; G D Dodd; R L Baron
Journal:  AJR Am J Roentgenol       Date:  1997-03       Impact factor: 3.959

Review 4.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

5.  90Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.

Authors:  Nadine Abouchaleh; Ahmed Gabr; Rehan Ali; Ali Al Asadi; Ronald A Mora; Joseph Ralph Kallini; Samdeep Mouli; Ahsun Riaz; Robert J Lewandowski; Riad Salem
Journal:  J Nucl Med       Date:  2017-12-07       Impact factor: 10.057

6.  Significance of platelet and AFP levels and liver function parameters for HCC size and survival.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Int J Biol Markers       Date:  2014-09-30       Impact factor: 2.659

7.  A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.

Authors:  Brian I Carr; Vito Guerra
Journal:  Oncology       Date:  2016-03-15       Impact factor: 2.935

8.  Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma.

Authors:  Sandro Rossi; Giorgia Ghittoni; Valentina Ravetta; Francesca Torello Viera; Laura Rosa; Martina Serassi; Mara Scabini; Alessandro Vercelli; Carmine Tinelli; Barbara Dal Bello; Peter N Burns; Fabrizio Calliada
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

9.  N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.

Authors:  Jun Akiba; Sachiko Ogasawara; Akihiko Kawahara; Naoyo Nishida; Sakiko Sanada; Fukuko Moriya; Michihiko Kuwano; Osamu Nakashima; Hirohisa Yano
Journal:  Oncol Rep       Date:  2008-12       Impact factor: 3.906

View more
  1 in total

1.  Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.

Authors:  Lukas Müller; Felix Hahn; Timo Alexander Auer; Uli Fehrenbach; Bernhard Gebauer; Johannes Haubold; Sebastian Zensen; Moon-Sung Kim; Michel Eisenblätter; Thierno D Diallo; Dominik Bettinger; Verena Steinle; De-Hua Chang; David Zopfs; Daniel Pinto Dos Santos; Roman Kloeckner
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.